Education
Study offer
Work-Study
Bordeaux Summer Schools
Admissions
How to register
Keep track of your education
Support and success in your studies
Enrich and enhance your experience
Research
Scientific vision
Major Research Programmes (GPRs)
Impulsion Research Networks
Open Science
Ethics in research
Research organisation
Research departments
Boost your research
Innovation and the socio-economic sphere
Science and society
Campus
Discover the campus
Campus life and activities
Daily life
Social and financial aid
Sense of community & social cohesion
Culture
Sports
International
International ambition
International partners
Come to Bordeaux
International students
International PhD students
International lecturers, researchers and staff
Opportunities abroad
Student mobility
Partnerships abroad
About us
Get to know us
Our strategy
Institutional projects
An outreaching, extended university
Our commitments
Societal and environmental transitions
Organisation and operations
Training components
University employment
She/he/they make up the University of Bordeaux
Our Honoris Causa
Press corner
Most searched pages
Frequent search terms
Updated on: 16/07/2024
On Thursday 11th July 2024, the VBHI (Vascular Brain Health Institute) University-Hospital Institute was officially launched in the presence of representatives of all it's founding institutions. This new institute in Bordeaux is committed to conducting cutting-edge research on cerebral diseases.
Cerebrovascular health is a major public health issue worldwide: strokes are the second most common cause of death in the world and the leading cause of death among women in France, affecting 100 million people globally. Strokes can also lead to dementia, which affects 57 million people worldwide. It is estimated that 400 million people suffer from small cerebral vessel disease, which can lead to the serious consequences mentioned above.
Stéphanie Debette, professor at the University of Bordeaux and Bordeaux University Hospital, and director of the Bordeaux Population Health research centre (University of Bordeaux, Inserm), presented this institute, which promotes transformative research. Such research will lead to better prevention of strokes and dementia as well as better care for the millions of people currently affected in France and around the world.
The VBHI University-Hospital Institute focuses on three challenges:
The launch of this new University-Hospital Institute dedicated to brain vascular health also demonstrates the influence of the University of Bordeaux ecosystem, which is now home to two University-Hospital Institutes on its campus. This institute further positions the University of Bordeaux as a leading university in the field of biomedical research on a national scale.
The institute is coordinated by the University of Bordeaux and supported by Bordeaux University Hospital, Inserm, Inria and the Nouvelle-Aquitaine Region.
Access the website (in French)
Two round tables punctuated the launch, illustrating the diversity of the institutions involved in the institute and the central role role played by innovation in VBHI's operations.
This round table brought together speakers with a wide range of scientific, medical and technological expertise (neurology, public health, neurosciences, chemistry, physiology, imaging, artificial intelligence, etc.), illustrating the multidisciplinary nature of the institute, which aims at developing research focused on innovation extending from the population to the patient's bedside (translational research).
This pursuit of innovation is illustrated by multiple projects. Among which, the objective of discovering new drugs by repositioning existing therapeutic molecules and generating new innovative therapeutic compounds, prevention and personalised ("precision") medicine, and the development of new medical imaging technologies that are less costly, less energy-intensive and more mobile (low-field MRI), facilitating early diagnosis of small cerebral vessel disease and enabling treatment to be optimised.
The meeting of speakers with complementary expertise (doctors, representatives of patient associations, researchers, etc.) illustrated the institute's integrated approach to tackling the challenges of better prevention and management of cerebrovascular disease.
Drawing in particular on the testimony of the association "AVC tous concernés" ("Stroke, all involved"), the speakers highlighted the need to develop preventive approaches that are implemented earlier and more effectively, in order to target as many people as possible, with the aim of reducing inequalities in access in France and around the world, while at the same time being more personalised - taking into account the diversity of biological profiles of diseases and the specific characteristics, particularly genetic, of each individual. Involving patients in research was also mentioned as a success factor, particularly through concrete actions such as 'living labs' in New Aquitaine. The importance of close partnerships with innovative international institutions, including in countries in the global south (in fundamental, clinical and public health research) was highlighted.
The VBHI institute has received financial support from the French government within the framework of France 2030 programme, managed by the Agence Nationale de la Recherche under the reference "ANR-23-IAHU-0001".
